25021-263-10 : NDC 2026 Code

25021-263-10 : Doxorubicin Hydrochloride ( Doxorubicin Hydrochloride Liposome )

Additionally :

You can get information about “25021-263-10” NDC code in 25021-263-10 in HTML format

HTML | 25021-263-10 in TXT (Plain Text) format

TXT | 25021-263-10 in PDF (Portable Document Format)

PDF | 25021-263-10 in XML format

XML formats.

NDC Code : 25021-263-10 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "25021-263-10",
    "PackageDescription": "1 VIAL in 1 CARTON (25021-263-10)  / 10 mL in 1 VIAL",
    "NDC11Code": "25021-0263-10",
    "ProductNDC": "25021-263",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Doxorubicin Hydrochloride Liposome",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Doxorubicin Hydrochloride",
    "DosageFormName": "INJECTION, SUSPENSION, LIPOSOMAL",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20260301",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA219881",
    "LabelerName": "Sagent Pharmaceuticals",
    "SubstanceName": "DOXORUBICIN HYDROCHLORIDE",
    "StrengthNumber": "2",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-03-04",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260301",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}